These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 10974754

  • 1. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH, Tsai CS, Wang CC, Lai CH, Chen WC, Lee SP, Chang TC, Tseng CJ.
    Chang Gung Med J; 2000 Jul; 23(7):396-404. PubMed ID: 10974754
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
    Zhou J, Wu SG, Sun JY, Li FY, Lin HX, Chen QH, He ZY.
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
    [Abstract] [Full Text] [Related]

  • 3. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

  • 4. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL, Huang CY, Huang YS, Chen RJ, Wang CW, Chen YH, Cheng JC, Cheng AL, Kuo SH.
    Acta Obstet Gynecol Scand; 2014 Jul 01; 93(7):661-8. PubMed ID: 24666257
    [Abstract] [Full Text] [Related]

  • 5. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E, Mabuchi S, Takahashi R, Matsumoto Y, Kuroda H, Kozasa K, Kimura T.
    J Gynecol Oncol; 2017 Mar 01; 28(2):e19. PubMed ID: 28028992
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 7. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH, Tsai CS, Chang JT, Wang CC, Lai CH, Lee SP, Tseng CJ, Chang TC, Tang SG.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):823-30. PubMed ID: 9652844
    [Abstract] [Full Text] [Related]

  • 8. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, Kim JY, Huh SJ.
    Gynecol Oncol; 2014 Mar 01; 132(3):618-23. PubMed ID: 24486605
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A, Nakano T, Morita S, Oka K.
    Anticancer Res; 1999 Mar 01; 19(1B):829-36. PubMed ID: 10216501
    [Abstract] [Full Text] [Related]

  • 10. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):492-9. PubMed ID: 15925454
    [Abstract] [Full Text] [Related]

  • 11. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA.
    Cancer; 2003 May 01; 97(9):2196-202. PubMed ID: 12712471
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
    Volgger B, Aspisirengil C, Genser-Krimbacher E, Ciresa-Koenig A, Daxenbichler G, Fuchs D, Windbichler G, Marth C.
    Cancer Lett; 2008 Apr 18; 262(2):183-9. PubMed ID: 18226853
    [Abstract] [Full Text] [Related]

  • 13. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
    Zhang X, Lv Z, Xu X, Yin Z, Lou H.
    BMC Cancer; 2020 Jul 16; 20(1):664. PubMed ID: 32678039
    [Abstract] [Full Text] [Related]

  • 14. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S, Kojima A, Maeno Y, Oki N, Miyahara Y, Sudo T, Takekida S, Yamaguchi S, Nishimura R.
    Kobe J Med Sci; 2006 Jul 16; 52(1-2):9-15. PubMed ID: 16547424
    [Abstract] [Full Text] [Related]

  • 15. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 16; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 16. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199
    [Abstract] [Full Text] [Related]

  • 17. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 Nov 01; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 18. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB, Winchester DP, Clive RE.
    Cancer; 1995 Nov 15; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [Abstract] [Full Text] [Related]

  • 19. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T.
    Surgery; 2003 May 15; 133(5):486-94. PubMed ID: 12773976
    [Abstract] [Full Text] [Related]

  • 20. Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.
    Song HW, Chen C, Shen HX, Ma L, Zhao YL, Zhang GJ, Geng ZM, Wang L.
    J Surg Oncol; 2015 Nov 15; 112(6):677-80. PubMed ID: 26458491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.